寡甘露糖型弥漫性大B细胞淋巴瘤的起源、诊断与预后
研究通过RNA测序免疫球蛋白组装和液相色谱-质谱分析,在2个独立DLBCL队列中确定获得性N-糖基化位点(AGS)的频率与CDR位置及其糖链组成。CDR定位的AGS见于41%至46%的GCB-DLBCL,但仅具有FL特征的DLBCL的CDR定位AGS被寡甘露糖型糖链占据,称为Mann型DLBCL。Mann型状态是短无进展生存和总生存的独立标志物,而其他GCB-DLBCL包括有FL特征但无AGS者预后最佳。
要点
- CDR定位的AGS见于41%至46%的GCB-DLBCL,其他DLBCL罕见。
- 仅具有FL特征的DLBCL的CDR定位AGS被寡甘露糖型糖链占据,称为Mann型DLBCL。
- Mann型状态是短无进展生存和总生存的独立标志物。
核心结论
- Mann型糖链的获得是高度选择性的环境压力,能够识别一种与FL起源相关的侵袭性GCB-DLBCL类型。
- 在具有FL特征的GCB-DLBCL的CDR中检测AGS可定义Mann型DLBCL,细化预后,并标记一个精确的肿瘤相互作用以供早期治疗阻断。
研究设计与样本
- 利用RNA测序免疫球蛋白组装在2个独立DLBCL队列中确定获得性N-糖基化位点(AGS)的频率和CDR位置。
- 使用液相色谱-质谱法确定占据AGS的糖链组成,并与细胞起源、FL特征(由EZB表型或BCL2易位定义)、转录谱和临床结局进行关联分析。
主要发现
- CDR定位的AGS见于41%至46%的GCB-DLBCL,但在其他DLBCL中罕见。
- 仅具有FL特征的DLBCL的CDR定位AGS被寡甘露糖型糖链占据,这些DLBCL被命名为Mann型DLBCL;其他DLBCL的AGS要么未被糖基化,要么被复杂型糖链占据。
- Mann型状态是短无进展生存和总生存的独立标志物;相反,其他GCB-DLBCL包括有FL特征但无AGS者结局最佳。
- Mann型DLBCL过表达细胞生长、存活和循环相关基因集,低表达促炎和凋亡通路,与是否伴有MYC易位无关。
关键数值与推荐
- CDR定位的AGS在GCB-DLBCL中的频率为41%至46%。
临床怎么用
- 在具有FL特征的GCB-DLBCL的CDR中检测AGS可定义Mann型DLBCL并细化预后。
- Mann型状态标记一个精确的肿瘤相互作用,可供早期治疗阻断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The acquisition of N-glycosylation sites that are occupied by oligomannose-type glycans in the immunoglobulin complementarity-determining region (CDR) is an early, clonal, tumor-specific identifier of follicular lymphoma (FL). CDR-located N-glycosylation sites are also acquired in germinal center B-cell-like diffuse large B-cell lymphomas (GCB-DLBCLs), but their significance is less defined. We used RNA sequencing immunoglobulin assembly to determine frequency and CDR location of the acquired N-glycosylation sites (AGSs) in 2 independent DLBCL cohorts. Composition of the glycans occupying the AGSs was determined using liquid chromatography-mass spectrometry and correlated with cell of origin, FL signature (defined by EZB phenotype or BCL2 translocation), transcript profile, and clinical outcome. CDR-located AGSs were observed in 41% to 46% of GCB-DLBCLs but were rare in other DLBCLs. Only CDR-located AGSs of DLBCL with an FL signature were occupied by oligomannose-type glycans. These DLBCLs were termed Mann-type DLBCL. Conversely, the AGSs of the other DLBCLs were either nonglycosylated or occupied by complex-type glycans. Mann-type status was an independent marker of short progression-free survival and overall survival. In contrast, the other GCB-DLBCLs, including those with an FL signature but without AGSs, had the best outcomes. Mann-type DLBCLs overexpressed gene sets of cell growth, survival, and cycling, and underexpressed proinflammatory and apoptotic pathways, irrespective of the presence of concomitant MYC translocations. The acquisition of Mann-type glycans is a highly selective environmental pressure enabling the identification of an aggressive GCB-DLBCL type with origin related to FL. The detection of AGSs in the CDR of GCB-DLBCLs with an FL signature defines Mann-type DLBCLs, refines prognosis, and marks a precise tumor interaction to block early therapeutically.
引用
- Tatterton DJ, Newby ML, Allen JD, et al. The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma. Blood. 2025. PMID: 40896832. doi:10.1182/blood.2025029163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。